Signal · Regulation & Trade

Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates; Guidance for Industry; Availability

US Federal Register - FDA (food, drug, device rules) Authoritative source Published 9th September 2026 United States

Open original report federalregister.gov

What the source reported

Source-reported

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a guidance for industry titled "Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates." This guidance describes the FDA's regulatory and enforcement priorities regarding the compounding of certain starter parenteral nutrition drug products for neonates by outsourcing facilities and by State-licensed pharmacies and Federal facilities that are not registered with FDA as outsourcing facilities. This guidance is being published for immediate implementation due to the expected market exit of the predominant source of certain starter parenteral nutrition drug products for neonates in the United States.

Publication: US Federal Register - FDA (food, drug, device rules) · Government/Regulator
Published: 9th September 2026
Original report: federalregister.gov

ProcIntel stores what the source published in its feed — a headline, a summary and a link. It does not store or reproduce the full article.

What ProcIntel recorded

ProcIntel-derived

Category: Regulation & Trade
Geography: United States
Organisations: None identified
Collected: 28th September 2026 · 16:32

Initial assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.

A provisional, automatically computed reading of this individual Signal, before Event extraction or human review. Not a final rating.

Significance 1 · Low

Confidence 2 · Low

Initial Significance Low (15.0/100). Strongest contributor: Procurement Impact (6.0/30 points). Limiting factor: Impact-Scale Specificity (0.0/10 points). Initial Confidence Low (39/100, data sufficiency: Insufficient). Strongest contributor: Source Authority (40.0/40 points). Limiting factor: Specificity (0.0/20 points). Capped at 39 (Low) -- insufficient structured evidence to support a higher Confidence reading, regardless of source authority.

Strongest contributor: Procurement Impact
Limiting factor: Impact-Scale Specificity

What the source reported

What ProcIntel recorded

Initial assessment ⓘMore about Initial Signal AssessmentProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.

Initial assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.